XRP, Quant and Injective near key breakout levels this week

What happened

Analyst Ali Martinez named Ripple's XRP, Quant (QNT) and Injective (INJ) as altcoins poised for a breakout as early as this week. The call came after BTC and most altcoins were rejected from their Monday peaks, with BTC sliding from $87,000 to $85,000 in the correction that followed.

For XRP, Martinez said the token appears to have broken above the descending resistance line of a triangle on the four-hour chart, with a next target at $1.62 as long as $1.50 holds as support. XRP was stopped at $1.53 and has since dipped to just under $1.50. CryptoQuant's CW said the positive trend remains intact.

Quant drew attention after major banking adoption news, rising by 530% at one point within days from $59 to $370 before it was stopped, and it now trades at $255. Martinez said an hourly close above $262 would confirm the breakout he is watching and put $315 and $344 in focus.

Injective slipped to $7.50 and remained relatively stagnant for about a week. Martinez said that as long as it stays above the neckline of its cup-and-handle formation at $7.33, the pattern points toward $13.40.

Why it matters

A second report puts the same three tokens on watch with different levels. XRP is holding near $1.51, with buyers defending the $1.50 range and the $1.55 to $1.60 zone as the key hurdle. A breakout above $1.60 could open the way toward $1.70.

That report says Quant has the strongest momentum of the three. The token is consolidating near $250 to $260, with the next hurdle around $270 to $275, a break and hold above $275 could point to $300 and beyond, and the Supertrend has just flipped bullish.

For Injective, the report notes a steady recovery after support near the $7 range, with the price around $7.56 and $8 as resistance. A sustained move above $8 would bring $8.75 and $9.80 into focus.

What the data shows

• XRP's RSI is around 57 and its CMF is close to neutral at -0.01, which the report says suggests buying pressure is yet to strengthen significantly.
• Quant went from below $100 to about $258, according to the second report.
• Injective topped $8.50 for the first time in almost a year after a correction to $4.60 and two surges in September.
• Martinez also said a surge past $430 could open the door to a major expansion to $2,000, a view he held before the retracement.

What is still unclear

• The total crypto market cap has fallen by about $50 billion since the previous morning, which the report says casts doubt on whether the three tokens can close above Martinez's targets.
• A decisive close below $1.50 would likely invalidate the analyst's XRP scenario.
• Quant volatility remains high after the rally, and holding above $250 would keep the bullish setup intact.
• Failure to break resistance could keep INJ within its current rising structure for longer.

Questions readers ask